United States: Federal Circuit Helps Clarify What Constitutes a Commercial Sale under Pfaff

In The Medicines Co. v. Hospira Inc., Appeal No. 2014-1469 (Fed. Cir. July 11, 2016), the Federal Circuit issued a unanimous en banc decision ruling that the on-sale bar was not triggered by a supplier's sale of manufacturing services to an inventor largely because the title to the invention and the right to market the invention never passed from the inventor to the supplier.


The Medicines Company (MedCo) contracted with Ben Venue Laboratories (Ben Venue) to manufacture Angiomax, a drug product, which is covered by two of MedCo's patents (U.S. Patent Nos. 7,582,727 and 7,598,343).  Slip op. at 5.  Before the critical date from which the on-sale bar of § 102(b) must be measured, MedCo paid Ben Venue a fee to manufacture three batches of product according to the patents-at-issue.  Slip op. at 6-7.  The batches were provided by Ben Venue and placed in quarantine with MedCo's distributor, and only released and made available for sale after the critical on-sale bar date.  Slip op. at 7-8.

MedCo sued Hospira in district court alleging infringement of the '727 and '343 patents.  Slip op. at 8.  Hospira contended that MedCo failed to prove infringement and alleged several grounds of invalidity, including that the invention was sold or offered for sale before the critical date under § 102(b).  Slip op. at 8-9.  The district court found the patents not invalid and not infringed.  Id.  MedCo and Hospira both appealed.  Slip op. at 10-11.  A merits panel of the Federal Circuit agreed with Hospira and reversed the district court's ruling regarding the applicability of the on-sale bar, and found that, "where the evidence clearly demonstrated that the inventor commercially exploited the invention before the critical date, even if the inventor did not transfer title to the commercial embodiment of the invention," the on-sale bar applies.  Slip op. at 11 (quoting Meds. Co. v. Hospira, Inc., 791 F.3d 1368, 1370-71 (Fed. Cir. 2015)).  Because the panel found the patents invalid, it did not reach other issues raised on appeal.

MedCo petitioned for rehearing en banc, which was granted on November 13, 2015.  Slip op. at 12-13.  The en banc Court ordered new briefing on (1) whether the circumstances presented constitute a commercial sale under the on-sale bar of 35 U.S.C. § 102(b), and (2) should this court overrule or revise the principle in Special Devices, Inc. v. OEA, Inc., 270 F.3d 1353 (Fed. Cir. 2001), that there is no "supplier exception" to the on-sale bar of 35 U.S.C. § 102(b)?  Slip op. at 13.

MedCo's position was "that the on-sale bar is not triggered by an inventor's retention of a third party to develop or manufacture the claimed invention confidentially and under the inventor's discretion and control," "that stockpiling does not constitute commercial activity under § 102(b)," and "that § 102(b) should not apply because no products were placed in the public domain prior to the critical date."  Slip op. at 13 (internal quotations omitted).

Hospira's position was that "MedCo's transactions with Ben Venue constitute a commercial sale under § 102(b) because this arrangement constituted commercial exploitation from the standpoint of both companies."  Id. (internal quotations omitted).


Under Pfaff, the on-sale bar under 35 U.S.C. § 102(b) applies when, before the critical date, the claimed invention (1) "was the subject of a commercial offer for sale" and (2) "was ready for patenting."  Slip op. at 17 (citing Pfaff v. Wells Electronics, Inc., 525 U.S. 55, 67 (1998)).

The Court focused on the first prong of the Pfaff test in determining that the on-sale bar did not apply, and discussed, broadly speaking, three reasons for their judgment.

First, only manufacturing services were sold by Ben Venue to MedCo, the invention (the formulated drug product itself) was not.  Slip op. at 19.  The Court considered several factors in coming to this conclusion, which included a review of the cases on which Hospira relied, the instructions provided by MedCo to Ben Venue, the invoices for the manufacturing services, and the amount MedCo paid for the batches of product.  Id.  Each factor led the Court to conclude that the transaction between MedCo and Ben Venue was for manufacturing services, and that Ben Venue acted as a pair of "laboratory hands" to reduce MedCo's invention to practice.  Id.  Therefore, under the plain text of § 102(b), there was no sale of the "invention."  Id.

Second, MedCo maintained control of the invention, as shown by the retention of title to the embodiments and the absence of any authorization to Ben Venue to sell the product to others.  Slip op. at 19.  In coming to this conclusion, the Court looked to the Uniform Commercial Code (UCC) for the definition of a "sale."  Slip op. at 23.  The UCC describes a "sale" as "passing of title from the seller to the buyer for a price."  Slip op. at 22 (quoting U.C.C. § 2-106(1)).  Although the Court didn't set a bright line rule, the Court mentioned that the passage of title is a helpful indicator of whether the inventor gives up its interest and control over the product, and conversely, that the retention of title indicates an absence of commercial marketing of the product.  Slip op. at 22-23.  Additionally, the Court considered the confidential nature of the transaction, and concluded that the scope and nature of the confidentiality imposed on Ben Venue favors the view that the transaction was not commercial in nature.  Slip op. at 23-24.  Therefore, since (1) MedCo maintained control of the invention, (2) the invention was not commercially marketed, and (3) the transaction was not commercial in nature, there was no "sale" of the invention.  Slip op. at 25-26.

Lastly, "stockpiling," standing alone, does not trigger the on-sale bar.  Slip op. at 19.  Hospira argued that stockpiling the invention would permit MedCo to commercially benefit from the manufacturing services.  Slip op. at 26.  However, the Court pointed out that commercial benefit is not what triggers § 102(b); there must be a commercial sale or offer for sale.  Id.  The mere preparation or eventual marketing of the invention is not enough to trigger § 102(b).  Id.

Also, the Court did not overrule Special Devices, which held that there is no "supplier exception" to the on-sale bar.  Instead, the Court noted that "the import of Special Devices is simply that the fact that a sale is made by a supplier is not, standing alone, sufficient grounds upon which to characterize a transaction having all of the hallmarks of a commercial sale under the UCC as something other than a commercial sale."  Slip op. at 30.


This en banc decision helps clarify what constitutes a commercial offer for sale in the manufacturing services context.  Although the Court did not set a bright-line rule, suppliers and inventors looking to engage in a manufacturing services agreement will now have more guidance as to what events may trigger an on-sale bar under § 102(b).

In the Pfaff decision, the Supreme Court focused on the second prong of the on-sale bar test, "ready for patenting," and said little about the first prong, "commercial offer for sale."  And precedent related to the commercial offer for sale of manufacturing services primarily focuses on performing a claimed method or process (e.g., Metallizing Engineering Co., D.L. Auld, Plumtree, and Scaltech).

Here, the invention was directed towards a drug product, Angiomax.   Therefore, to determine what constitutes a commercial offer for sale of a product, the Court laid out several factors, such as the nature of the transaction and the control over the invention, and discussed various indicators that help weigh each of the factors — factors that innovators should consider when contracting for manufacturing services.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions